Indo US Bio-Tech (BOM:541304) Cash And Cash Equivalents : ₹2.5 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Indo US Bio-Tech Cash And Cash Equivalents?

Indo US Bio-Tech's quarterly cash and cash equivalents declined from Sep. 2024 (₹10.42 Mil) to Dec. 2024 (₹0.00 Mil) but then increased from Dec. 2024 (₹0.00 Mil) to Mar. 2025 (₹2.48 Mil).

Indo US Bio-Tech's annual cash and cash equivalents declined from Mar. 2023 (₹1.34 Mil) to Mar. 2024 (₹0.49 Mil) but then increased from Mar. 2024 (₹0.49 Mil) to Mar. 2025 (₹2.48 Mil).

Indo US Bio-Tech Cash And Cash Equivalents Historical Data

The historical data trend for Indo US Bio-Tech's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo US Bio-Tech Cash And Cash Equivalents Chart

Indo US Bio-Tech Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Cash And Cash Equivalents

Get a 7-Day Free Trial

1.34

0.48

1.34

0.49

2.48

Indo US Bio-Tech Quarterly Data
	Oct17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Jun22	Sep22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24	Dec24	Mar25
Cash And Cash Equivalents	Get a 7-Day Free Trial															-	0.49	10.42	-	2.48

Indo US Bio-Tech Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Indo US Bio-Tech (BOM:541304) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Indo US Bio-Tech Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Indo US Bio-Tech's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Indo US Bio-Tech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Indo US Bio-Tech Ltd (BOM:541304) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

INDOUS:India

Address

Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061

Website

https://www.indousagriseeds.com

Indo US Bio-Tech Ltd is engaged in the trading of agricultural seeds. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of agriculture crops. The company's product categories include vegetables; cotton seeds; oilseeds; spices seeds; pulses seeds and cereals seeds. The company has two segments which include Agricultural Activities and Trading Activities out of which it generates the key revenue from the Agricultural Activities.

Indo US Bio-Tech Headlines

No Headlines